نتائج البحث - "Rosemary Greenhalgh"

المصدر: Cancers, Vol 12, Iss 3697, p 3697 (2020)
Cancers
Volume 12
Issue 12
Howell, A, Gandhi, A, Howell, S, Wilson, M, Maxwell, A, Astley, S, Harvie, M, Pegington, M, Barr, L, Baildam, A, Harkness, E, Hopwood, P, Wisely, J, Wilding, A, Greenhalgh, R, Affen, J, Maurice, A, Cole, S, Wiseman, J, Lalloo, F, French, D P & Evans, D G 2020, ' Long-term evaluation of women referred to a breast cancer family history clinic (Manchester UK 1987–2020) ', Cancers, vol. 12, no. 12, 3697, pp. 1-19 . https://doi.org/10.3390/cancers12123697

مصطلحات موضوعية: Risk, Cancer Research, medicine.medical_specialty, Breast surgery, medicine.medical_treatment, Family history, Population, Anastrozole, lcsh:RC254-282, Article, 03 medical and health sciences, Breast cancer, breast cancer, 0302 clinical medicine, prevention, medicine, 030212 general & internal medicine, genes, education, risk, family history, education.field_of_study, Manchester Cancer Research Centre, business.industry, Obstetrics, Prevention, ResearchInstitutes_Networks_Beacons/mcrc, screening, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Genes, Oncology, 030220 oncology & carcinogenesis, Screening, Population Risk, business, Risk assessment, Tamoxifen, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d9c80028e80f160fbae08ca67ae341
https://doi.org/10.3390/cancers12123697

Find this article in full text from ProQuest

5

RAZOR: A phase II open randomized trial of screening plus goserelin and raloxifene versus screening alone in premenopausal women at increased risk of breast cancer

المؤلفون: D. Gareth Evans, Judith E. Adams, Rosalind A. Eeles, Lesley Fallowfield, Adam R. Brentnall, Linda Ashcroft, Jamie Motion, Rosemary Greenhalgh, Ann Ward, Mitchell Dowsett, Caroline Boggis, Anthony Howell, Jack Cuzick, Diana Eccles, Jamie C. Sergeant

المصدر: Howell, A, Ashcroft, L, Fallowfield, L, Eccles, D M, Eeles, R A, Ward, A, Brentnall, A R, Dowsett, M, Cuzick, J, Greenhalgh, R, Boggis, C, Motion, J, Sergeant, J, Adams, J & Evans, D 2018, ' RAZOR: A phase II open randomized trial of screening plus goserelin and raloxifene versus screening alone in premenopausal women at increased risk of breast cancer ', Cancer Epidemiology, Biomarkers & Prevention, pp. 58-66 . https://doi.org/10.1158/1055-9965.EPI-17-0158, https://doi.org/10.1158/1055-9965.EPI-17-0158

مصطلحات موضوعية: Oncology, Adult, R853.C55, medicine.medical_specialty, Bone density, Antineoplastic Agents, Hormonal, Epidemiology, RC0280.B8, Breast Neoplasms, raloxifene, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Bone Density, Internal medicine, medicine, Humans, Mass Screening, Raloxifene, 030212 general & internal medicine, Breast, Mass screening, Breast Density, Gynecology, Bone Density Conservation Agents, Manchester Cancer Research Centre, business.industry, Raloxifene Hydrochloride, Prevention, ResearchInstitutes_Networks_Beacons/mcrc, Goserelin, Cancer, trial, medicine.disease, 030220 oncology & carcinogenesis, randomized, Quality of Life, Patient Compliance, Drug Therapy, Combination, Female, RC0261, business, Tamoxifen, medicine.drug, Mammography

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document; text; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a42479132eacfdfbd3412f91f4e00f
https://research.manchester.ac.uk/en/publications/b3a933cd-fff9-459c-afd8-0ccdfd5957c4

6

Abstract P1-09-05: The RAZOR trial: a phase II prevention trial of screening plus goserilin and raloxifene versus screening alone in pre-menopausal women at increased risk of breast cancer

المؤلفون: Diana Eccles, A Howell, Linda Ashcroft, Jenny Affen, Gareth Evans, Rosalind A. Eeles, Jack Cuzick, C Boggis, Jamie C. Sergeant, J Adams, J Motion, Rosemary Greenhalgh, J Hickman, Sara Bundred, Lesley Fallowfield, Mitchell Dowsett

المصدر: Cancer Research. 72:P1-09

مصطلحات موضوعية: Gynecology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Goserelin, Oophorectomy, Cancer, medicine.disease, Breast cancer, Oncology, Quality of life, Median follow-up, Internal medicine, medicine, Anxiety, Raloxifene, medicine.symptom, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4f7482c023a74bc98155e647859fcb1e
https://doi.org/10.1158/0008-5472.sabcs12-p1-09-05

7

Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer

المؤلفون: D. Gareth Evans, Jenny Affen, Lesley Ann Flook, Eugene V. McCloskey, Sue Ashley, Anthony Howell, Trevor J. Powles, Rosemary Greenhalgh, A. Tidy

المصدر: Powles, T J, Howell, A, Evans, D G, McCloskey, E V, Ashley, S, Greenhalgh, R, Affen, J, Flook, L A & Tidy, A 2008, ' Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer ', Menopause International, vol. 14, no. 1, pp. 6-12 . https://doi.org/10.1258/mi.2007.007033